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To determine the prevalence of Mycobacterium tu-
berculosis infection among dental patients and to assess 
dentists’ risk for exposure, we conducted a study among 
dental patients at a large tertiary hospital in Nigeria, a coun-
try where tuberculosis is endemic. Ten (13%) of 78 sputum 
samples obtained were positive for M. tuberculosis.
Tuberculosis (TB) is a serious public health concern glob-ally, and almost half of new infections are undetected 
(1). The infection is spread by airborne droplet nuclei that 
contain Mycobacterium tuberculosis, which remain airborne 
for minutes to hours after expectoration through coughing, 
sneezing, or talking by persons with pulmonary TB (2).
Acquisition of TB in healthcare facilities is a well-rec-
ognized hazard for healthcare workers and patients. Dental 
practitioners may be at increased risk because they work in 
close proximity to potentially infectious secretions (3). The 
risk is higher in areas like Nigeria, where TB is endemic; 
control practices are poor; and compliance with guidelines 
for preventing TB in healthcare facilities, such as those is-
sued by the US Centers for Disease Control and Prevention 
(4), is limited.
We initiated this study to assess the risk for exposure 
of dentists to M. tuberculosis infection and to determine 
its prevalence among dental patients. Participants were 
patients in the dental clinic of University College Hospi-
tal, Ibadan, Nigeria, the largest hospital in the country. 
The Study 
This study was conducted in the dental center of 
University College Hospital, a tertiary hospital located in 
Ibadan, Oyo State, southwestern Nigeria. Nigeria, which 
has a population of >140 million, is rated as fourth among 
TB-endemic nations, with a prevalence of 521 cases per 
100,000 population during 2007 (5). Ethical clearance for 
the study was obtained from the Oyo State Ethical Review 
Board as part of a multifocused study of TB in the state.
The dental center comprises 7 units that provide care 
to ≈1,800 patients annually. This study was carried out 
in the Oral Surgery Clinic, one of the units in the center 
where a member of the study team is a consultant. Patients 
were recruited during February 2006 through July 2007. 
A total of 312 consecutive patients who came to the clinic 
for treatment were invited to participate; 101 gave con-
sent (23/101 patients were excluded because they could 
not produce a sputum sample). Thus, 78 patients were 
evaluated.
Each participant completed a structured question-
naire that requested information about age, sex, occupa-
tion, bacille Calmette-Guérin (BCG) vaccination, history 
of chronic cough or TB, HIV status, and contact with a 
patient who had chronic cough or TB. A single expecto-
rated sputum sample was collected from each participant 
and placed in a sterile universal container. Collection was 
done through the support of medical house offi cers/regis-
trars posted to the unit; a consultant (1 of the study group 
members) was responsible for overall supervision.
The sputum specimen and culture were processed by 
using a standard procedure as described by Cadmus et 
al. (6). Using the Ziehl-Neelsen technique, we performed 
smear microscopy. Isolates were harvested for molecular 
typing analysis by scraping the growth from a slope into 
200 μL of distilled water and heating the product at 80ºC 
for 1 h.
Molecular identifi cation of isolates was conducted 
in the Veterinary Laboratories Agency, Addlestone, Sur-
rey, UK, by spoligotyping as described by Kamerbeek et 
al. (7) with minor modifi cations and repeated at the Center 
for Infectious Disease Control (RIVM) in the Netherlands. 
Furthermore, the Hain Genotype Mycobacterium tuber-
culosis complex (MTBC) test (Hain Lifescience, Nehren, 
Germany) was applied to determine whether an isolate was 
a member of the MTBC, after which the Hain line probe as-
say identifi cation kit for subspecies of MTBC was applied 
(Hain Lifescience).
Seventy-eight dental patients who could give a spu-
tum sample consented to participate in the study. Forty-
one (52%) participants were women; median age was 32 
years. A total of 20 participants (26%) reported having 
received BCG vaccine, and 10 reported prior exposure 
to a person with chronic cough or with TB. None of the 
participants reported a personal history of chronic cough 
or TB. Ten (13%) of the 78 participants had culture-con-
fi rmed TB, 7 of whom had initial positive acid-fast bacilli 
(AFB) smears through concentrated sputum samples. The 
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HIV status of 70 respondents (including those with TB) 
was unavailable, and 1 of the remaining 8 respondents 
reported being positive for HIV during questionnaire/
sample collection. The demographic characteristics, AFB 
smear results, BCG vaccination history, and known TB 
exposure of the participants with mycobacterial growth 
are presented in the Table.
Spoligotyping in the United Kingdom and repeated 
molecular identifi cation in the Netherlands identifi ed the 
strains as M. tuberculosis. In spoligotyping, different ge-
notypic patterns were visualized (8), which limited the pos-
sibility of laboratory cross-contamination.
Conclusions
In patients who sought treatment at the dental clinic 
of a tertiary hospital in Nigeria, we found an unexpect-
edly high rate of unrecognized infection with pathogenic 
mycobacteria. Ten (13%) of 78 study participants who 
provided sputum samples were infected with M. tubercu-
losis. Our fi ndings corroborate other studies of TB cases 
and show that AFB smears alone would miss some in-
fected patients. M. tuberculosis is transmitted with high 
effi ciency to household contacts (9), and transmission of 
mycobacteria, including multidrug-resistant M. tubercu-
losis strains, from dental patients to dental practitioners, 
probably occurs (10). Accordingly, infected participants 
in this study, especially those who had positive AFB 
smears, were, in principle, capable of infecting dental 
practitioners and other patients. Reports from other set-
tings suggest that the threat of TB transmission from cli-
ents to dentists is not only theoretical (11). This extremely 
high percentage of undiagnosed AFB positivity is of pub-
lic health concern because dental clinics in TB-endemic 
areas are not usually considered a place of high risk for 
TB transmission; therefore, preventive measures are not 
routinely implemented.
This study has several limitations. First, patients were 
recruited from only 1 of the 7 units in the dental center, 
constricting the pool of patients invited to participate. 
However, all patients visiting the center were exposed 
to similar conditions, and the patients who came to the 
oral surgery clinic had often been referred from other 
units in the dental center. Second, only 1 sputum sample 
was collected from each participant. The yield possibly 
would have been higher if we had collected more sam-
ples. Third, dental problems (12) and TB (13) are major 
comorbidities among persons infected with the HIV, and 
the synergism between M. tuberculosis and HIV is well 
documented. Because we did not collect complete histo-
ries on the HIV status of participants, we are unable to 
delineate the role of HIV with respect to our observations. 
However, in 2003, the same clinic recorded a 2.3% HIV 
prevalence among 300 patients screened for oral surgery 
(14); the 2008 prevalence data for the state was 2.2% (15). 
Fourth, our study was conducted in the dental clinic of the 
major tertiary hospital in 1 of the largest cities in Nigeria; 
thus, the fi ndings may not be generalizable to all facili-
ties where dental care is provided. Nevertheless, a sur-
prisingly high proportion of dental patients in this study 
had potentially infectious TB. Therefore, evidence-based 
strategies should be implemented to quickly diagnose TB 
and prevent its transmission in dental clinics. Of partic-
ular importance in preventing nosocomial TB in dental 
clinics will be the adoption of infection control measures 
that may include the use of appropriate masks. Finally, 
our study also emphasizes the view that active case fi nd-
ing in high prevalence settings could be benefi cial.
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Table. Demographic characteristics, BCG vaccination status, and TB exposure history of participants with positive sputum culture
results, University College Hospital, Ibadan, Nigeria, 2006–2007* 
Participant ID Age, y/sex Occupation BCG vaccination Exposure to TB patients Positive AFB smear 
1 49/F Hairdresser No No Yes 
2 60/M Trader Yes No Yes 
3 24/F None Yes No No
4 30/F Student No No Yes 
5 45/M Businessman Yes No Yes 
6 77/M Retired Yes No No
7 44/M Clergyman Yes No No
8 40/F Trader No Yes Yes 
9 63/M Retired Yes No Yes 
10 54/F Civil servant Yes No Yes 
*BCG, bacille Calmette-Guérin; TB, tuberculosis; ID, identification; AFB, acid-fast bacilli. 
Dentists and M. tuberculosis, Nigeria
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